Author:
Verleden Geert M.,Verleden Stijn E.
Publisher
Springer International Publishing
Reference45 articles.
1. Cooper JD, Billingham M, Egan T, Hertz MI, Higenbottam T, Lynch J, Mauer J, Paradis I, Patterson GA, Smith C, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993;12:713–6.
2. Royer PJ, Olivera-Botello G, Koutsokera A, et al. Chronic lung allograft dysfunction: a systematic review of mechanisms. Transplantation. 2016 Sep;100(9):1803–14.
3. Verleden SE, Sacreas A, Vos R, Vanaudenaerde BM. Verleden GM advances in understanding bronchiolitis obliterans after lung transplantation. Chest. 2016;150:219–25.
4. Vanstapel A, Verleden SE, Verbeken EK, et al. Beyond Bronchiolitis Obliterans: In-depth histopathologic characterization of Bronchiolitis Obliterans Syndrome after lung transplantation. J Clin Med. 2021 Dec;25(11):111.
5. Vanstapel A, Goldschmeding R, Broekhuizen R, et al. Connective Tissue Growth Factor is overexpressed in explant lung tissue and broncho-alveolar lavage in transplant-related pulmonary fibrosis. Front Immunol. 2021 May;25(12):661761.